Plasma Aβ42/Aβ40 and p-tau181 Predict Long-Term Clinical Progression in a Cohort with Amnestic Mild Cognitive ImpairmentZhenxu Xiao, Qianhua Zhao, Jiaying Lu et al.|Clinical Chemistry|2022Cited by 32
Changes in lifestyle, mood, and disease management among community-dwelling older adults during the COVID-19 pandemic in ChinaSaineng Ding, Chen Liang, Qiqi Lei et al.|Aging and Health Research|2022Cited by 4
Plasma Aβ42/Aβ40 and p‐tau181 are associated with clinical progression in amnestic mild cognitive impairment: An 8‐year longitudinal studyZhenxu Xiao, Ding Ding, Ke‐Liang Chen et al.|Alzheimer s & Dementia|2023Cited by 0